How common is hair loss with Norethindrone (progestin-only pill) birth control?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hair Loss with Norethindrone Birth Control

Hair loss is an uncommon but possible side effect of norethindrone (progestin-only pill) birth control, occurring due to its androgenic properties that can affect hair follicles in susceptible individuals.

Understanding Progestin-Only Pills and Hair Loss

Norethindrone is a first-generation progestin that, unlike combined oral contraceptives (COCs), lacks the counterbalancing anti-androgenic effects of estrogen. This creates important distinctions in side effect profiles:

  • Androgenic Activity: Norethindrone is derived from testosterone and has androgenic potential when used alone 1. This androgenic activity can potentially trigger hair loss in susceptible women.

  • Mechanism: The androgenic properties can affect the hair growth cycle by:

    • Binding to androgen receptors in hair follicles
    • Potentially increasing 5-alpha-reductase activity
    • Disrupting the normal anagen (growth) phase of hair follicles

Incidence and Evidence

While specific incidence data for norethindrone-associated hair loss is limited in the literature, the FDA drug label for norethindrone lists hair loss as a potential side effect 2. The evidence suggests:

  • Hair loss is listed among "other side effects" in the norethindrone drug information, though not among the most common side effects 2
  • Progestin-only contraceptives lack the protective anti-androgenic effects that combined pills offer 1
  • A research article specifically identified alopecia as an adverse reaction to high androgen index contraceptives 3

Risk Factors for Hair Loss with Norethindrone

Certain factors may increase the risk of experiencing hair loss with norethindrone:

  • Personal or family history of androgenic alopecia
  • Previous hair thinning with hormonal changes
  • Sensitivity to hormonal fluctuations
  • Higher baseline androgen levels

Comparison with Combined Oral Contraceptives

Combined oral contraceptives (COCs) containing both estrogen and progestin typically have a net anti-androgenic effect 1:

  • COCs increase sex hormone-binding globulin, which binds free testosterone
  • COCs reduce 5-alpha-reductase activity
  • COCs block androgen receptors
  • Some newer progestins (like drospirenone) have specific anti-androgenic properties

This explains why COCs are sometimes used to treat hair loss, while progestin-only methods may occasionally cause it.

Management Options for Those Experiencing Hair Loss

If hair loss occurs with norethindrone:

  1. Consider alternative contraception:

    • Switch to a combined oral contraceptive with anti-androgenic properties
    • Consider non-hormonal contraceptive options
    • Discuss COCs containing fourth-generation progestins like drospirenone, which have anti-androgenic effects 1
  2. Adjunctive treatments:

    • Topical minoxidil may help counteract hormone-related hair loss
    • Nutritional assessment to rule out contributing deficiencies

Important Considerations

  • Hair loss from hormonal contraceptives is typically diffuse (all over) rather than in patterns
  • Hair typically regrows after discontinuation of the triggering medication
  • The decision to change contraceptive methods should balance contraceptive needs with side effect concerns
  • Individual response to hormonal contraceptives varies significantly

Hair loss with norethindrone is not a common side effect for most users, but for those who experience it, the impact on quality of life can be significant, warranting consideration of alternative contraceptive options.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Alopecia due to high androgen index contraceptives.

JAAPA : official journal of the American Academy of Physician Assistants, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.